This theory is further supported by the observation that PKCδ up-regulation impels the neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of PD [271] and by the evidence that the inhibition of PKCδ transactivation offers neuroprotection in both cell cultures and animal models of PD [272]. Here, PRKCD is linked to Parkinson disease.